We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Marechale Capital Plc | LSE:MAC | London | Ordinary Share | GB0005401087 | ORD 0.8P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.05 | 1.00 | 1.10 | 1.05 | 1.05 | 1.05 | 100,000 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Investment Advice | 376k | -426k | -0.0040 | -2.63 | 1.11M |
From Apr 2019 to Apr 2024
TIDMMAC
RNS Number : 7262W
Marechale Capital PLC
12 December 2019
12 December 2019
Marechale Capital plc
("Marechale Capital" or the "Company")
Interim Results
Marechale Capital plc today announces its unaudited interim results for the six months ended 31 October 2019.
Chairman's Statement
Marechale Capital has had another challenging half year since we reported our final results for the year ended 30 April 2019 in August. Revenues for the six months of GBP173,000 (2018: GBP136,000), whilst up on last year, are below budget, resulting in a loss of GBP62,000 (2018: GBP184,000) after taking into account a gain of GBP29,000 (2018: GBP67,000) on the realisation of investments. The Balance Sheet has also reduced further to GBP103,000 (2018: GBP226,000).
Low revenues are largely due to a continuing challenging market for advising and raising capital for private, growth companies, leading to delays in the completion of transactions, and, whilst our deal flow remains strong, it is still taking longer to complete transactions. The Company has taken significant steps to reduce its overheads and has achieved a GBP100,000 reduction by locating to smaller offices and reducing salary expenses.
The Board of Marechale Capital continues to consider its options and its future strategy.
Mark Warde-Norbury
Chairman
For further information please contact:
Hot Features
Premium
Marechale Capital Tel: +44 (0)20 7628
Mark Warde-Norbury / Patrick Booth-Clibborn 5582
Cenkos Securities plc Tel: +44 (0)20 7397
Azhic Basirov 8900
Consolidated Income Statement (unaudited)
6 months ended 31 October 30 October
2019 2018
GBP GBP
Revenue 173,036 136,491
Cost of sales (41,129) (61,611)
----------- -----------
Gross profit 131,907 74,880
Administrative expenses (224,804) (325,927)
----------- -----------
Operating (loss)/profit (92,897) (251,047)
Investment revenues 28,937 67,389
(Loss)/profit before tax (63,960) (183,658)
Taxation - -
(Loss)/profit for the period (63,960) (183,658)
----------- -----------
(Loss)/profit per share (Pence) (Pence)
- Basic (0.1) (0.32)
- Diluted (0.1) (0.32)
Consolidated Balance Sheet (unaudited)
As at 31 October 31 October
2019 2018
GBP GBP
Non-current assets
Investment in associate - 14,038
Current assets
Available for sale investments 75,481 107,087
Trading investments 1,550 78,388
Trade and other receivables 72,309 80,485
Cash and cash equivalents 83,545 63,172
----------- -----------
232,885 329,132
----------- -----------
Total assets 232,885 343,170
Current liabilities
Trade and other payables (129,532) (117,107)
Total current liabilities (129,532) (117,107)
----------- -----------
Net assets 103,353 226,063
----------- -----------
Equity
Capital and reserves attributable to equity
shareholders
Share capital 461,449 461,449
Revaluation reserve - 25,826
Reserve for own shares (50,254) (50,254)
Retained losses (319,781) (210,958)
Reserve for share based payments 11,939 -
----------- -----------
103,353 226,063
-----------
Consolidated Cash Flow Statement
(unaudited)
6 months ended 31 October 31 October
2019 2018
GBP GBP
Net cash from operating activities
Operating (loss) (92,897) (251,047)
Provision for share based payments -
Operating cash flows before movements in
working capital (92,897) (251,047)
Movement in working capital
Decrease in receivables 32,896 120,689
(Decrease) in payables (34,497) (4,239)
(1,601) 116,450
----------- -----------
Operating cash flow (94,498) (134,597)
----------- -----------
Investment activities
Proceeds on disposal of available for sale
investments 29,443 91,529
Expenditure on available for sale
investments - (12,700)
Other - 600
Cash flow from investing activities 29,443 79,429
----------- -----------
Net (decrease)/ increase in cash
and cash equivalents (65,055) (55,168)
----------- -----------
Cash and cash equivalents at start of the
period 148,600 118,340
Cash and cash equivalents at end of the
period 83,545 63,172
(Decrease)/increase in cash and
cash equivalents (65,055) (55,168)
----------- -----------
This financial information has been prepared in accordance with IFRS and International Financial Reporting Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior period being reported on the same basis.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
IR FFAFLEFUSELE
(END) Dow Jones Newswires
December 12, 2019 10:08 ET (15:08 GMT)
1 Year Marechale Capital Chart |
1 Month Marechale Capital Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
